FLGT Earnings Fulgent Genetics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
Revenue
Net income
Reported EPS history
1–13 of 13
| FY 2018 | 2018-12-31 | -0.11 | 2019-03-22 | 10-K |
| FY 2018 | 2018-09-30 | -0.03 | 2019-03-22 | 10-K |
| FY 2018 | 2018-06-30 | -0.06 | 2019-03-22 | 10-K |
| FY 2018 | 2018-03-31 | -0.11 | 2019-03-22 | 10-K |
| FY 2018 | 2017-12-31 | -0.09 | 2019-03-22 | 10-K |
| FY 2018 | 2017-09-30 | -0.06 | 2019-03-22 | 10-K |
| FY 2018 | 2017-06-30 | 0.00 | 2019-03-22 | 10-K |
| FY 2018 | 2017-03-31 | 0.01 | 2019-03-22 | 10-K |
| FY 2017 | 2016-12-31 | 0.05 | 2018-03-20 | 10-K |
| FY 2017 | 2016-09-30 | -0.44 | 2018-03-20 | 10-K |
| FY 2017 | 2016-06-30 | -5.49 | 2018-03-20 | 10-K |
| FY 2017 | 2016-03-31 | -0.02 | 2018-03-20 | 10-K |
| FY 2016 | 2015-12-31 | -0.61 | 2017-03-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.